Subject Areas
This journal welcomes the papers from all clinical and pre-clinical medical disciplines.
Basic, translational and clinical research conducted through interdisciplinary collaborations, community-based research, studies on medical devices and artificial intelligence in the medical field are given priority in the journal.
Publication Ethics Statement
Developments and Experiments in Health and Medicine Editorial Board, in accordance with the “DEU Faculty of Medicine Journal Directive”, carries out its work by observing the ethical rules of international organizations [International Council of Medical Journal Editors (ICMJE), World Association of Medical Editors (WAME), Council of Science Editors (CSE), Committee on Publication Ethics (COPE) and European Association of Science Editors (EASE)].
Developments and Experiments in Health and Medicine takes the responsibility to enforce a rigorous peer-review together with strict ethical policies and standards to ensure to add high quality scientific works to the field of scholarly publication. Unfortunately, cases of plagiarism, data falsification, inappropriate authorship credit, and the like, do arise. To verify the originality of content submitted to our journals, articles sent to the journal are accepted with an iThenticate or Turnitin report. A maximum of 15% similarity is accepted as a result of the report. The author must perform the similarity report when uploading the article to the system. If the rate exceeds 15%, the article can be sent back to the author with the report.
Copyright / Open Access
Articles published in Developments and Experiments in Health and Medicine will be Open-Access articles distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International. The copyright is retained by the author(s).
Editorial Office
Contact us
Developments and Experiments in Health and Medicine Editorial Office
Address: Mithatpaşa Cad. No: 1606 Dokuz Eylül University Faculty of Medicine Dean Office 35340 İnciraltı-Balçova/İZMİR
Phone: +90 232 4122290
Publication Coordinator Müjde UZHAN
E-mail: dehm@deu.edu.tr
Editorial Board
On behalf of Dokuz Eylul University Faculty of Medicine Owner
Serdar BAYRAK, Dept. of Cardiovascular Surgery, İzmir, Türkiye
https://orcid.org/0000-0003-1458-9023
Administrators
Emel ULUSOY, DEUFM, Dept. of Pediatrics (Pediatric Emergency), İzmir, Türkiye
https://orcid.org/0000-0002-2827-1553
Pınar AKAN, DEUFM, Dept. of Biochemistry, İzmir, Türkiye
https://orcid.org/0000-0001-9211-1944
Editor in Chief
Hale ÖREN, DEUFM, Dept. of Pediatrics (Pediatric Hematology), İzmir, Türkiye
https://orcid.org/0000-0001-5760-8007
Assistant Editors
Naciye Sinem GEZER, MD, DEUFM, Dept. of Radiology, İzmir, Türkiye
https://orcid.org/0000-0002-0868-4545
Serap CİLAKER MIÇILI, MD, DEUFM, Dept. of Histology and Embryology, İzmir, Türkiye
https://orcid.org/0000-0002-9830-0989
Editors
Ahmet Okay ÇAĞLAYAN, DEUFM, Dept. of Medical Genetics İzmir, Türkiye
https://orcid.org/0000-0002-2332-322X
Alper OKYAR, İstanbul University Faculty of Pharmacy, Dept. of Pharmacology, İstanbul, Türkiye https://orcid.org/0000-0002-9891-5588
Ayça Arzu SAYINER, DEUFM, Dept. of Microbiology, İzmir, Türkiye
https://orcid.org/0000-0001-6750-2353
Banu KASAPOĞLU, DEUFM, Dept. of Physical Therapy and Rehabilitation, İzmir, Türkiye
https://orcid.org/0000-0002-5451-0757
Can ÖZÜTEMİZ, University of Minnesota, Dept. of Neuroradiology, Minnesota, USA
https://orcid.org/0000-0002-4893-9725
Canan Aslı UTİNE YILDIRIM, DEUFM, Dept. of Ophthalmology, İzmir, Türkiye
https://orcid.org/0000-0002-4131-2532
Caner ÇAVDAR, DEUFM, Dept. of Medicine (Nephrology), İzmir, Türkiye
https://orcid.org/0000-0002-2306-2429
Cenk UMAY, DEUFM, Dept. of Radiation Oncology, İzmir, Türkiye
https://orcid.org/0000-0002-8825-3891
David PEARCE, University of South Dakota Sanford School of Medicine, Dept. of Pediatrics, South Dakota, USA
https://orcid.org/0000-0002-0707-063X
Didem ÖZ, DEUFM, Dept. of Neurology, İzmir, Türkiye
https://orcid.org/0000-0002-0989-8553
Esin ERGÖNÜL, DEUFM, Dept. of Medical Education, İzmir, Türkiye
https://orcid.org/0000-0003-0126-8108
Erdem Erinç SİLİSTRELİ, DEUFM, Dept. of Cardiovascular Surgery, İzmir, Türkiye
https://orcid.org/0000-0001-6938-2332
Gazi ARSLAN, DEUFM, Dept. of Pediatrics (Pediatric Intensive Care), İzmir, Türkiye
https://orcid.org/0000-0002-8616-3761
Gökçen ÖMEROĞLU ŞIMŞEK, DEUFM, Dept. of Chest Diseases, İzmir, Türkiye
https://orcid.org/0000-0002-2724-0616
Gülden AKDAL, DEUFM, Dept. of Neurology, İzmir, Türkiye
https://orcid.org/0000-0002-2486-4490
Hikmet TUNÇ TİMUR, DEUFM, Dept. of Obstetrics & Gynecology, İzmir, Türkiye
https://orcid.org/0000-0002-1250-8579
Mazhar ADLI, Northwestern University, Feinberg School of Medicine, Robert Lurie Comprehensive Cancer Center, Dept. of Obstetrics and Gynecology and Biochemistry and Molecular Genetics, Chicago, USA
https://orcid.org/0000-0003-4740-9594
Mualla Aylin ARICI, DEUFM, Dept. of Pharmacology, İzmir, Türkiye
https://orcid.org/0000-0003-2221-9356
Muhlis Cem AR, İstanbul University Cerrahpaşa, Dept. of Medicine (Hematology and Immunology), İstanbul, Türkiye
https://orcid.org/0000-0002-0332-9253
Nilay DANIŞ, DEUFM, Dept. of Medicine (Gastroenterology), İzmir, Türkiye
https://orcid.org/0000-0002-3939-3089
Nur ARSLAN, DEUFM, Dept. of Pediatrics (Pediatric Gastroenterology and Pediatric Metabolism), İzmir, Türkiye
https://orcid.org/0000-0003-3151-3741
Osman YILMAZ, DEU Institute of Health Sciences, Dept. of Laboratory Animals, İzmir, Türkiye
https://orcid.org/0000-0001-7817-7576
Serap AKSOYLAR, Ege University, Faculty of Medicine, Dept. of Pediatrics (Pediatric Oncology), İzmir, Türkiye
https://orcid.org/0000-0002-8446-0834
Tayfun BİŞGİN, DEUFM, Dept. of General Surgery, İzmir, Türkiye
https://orcid.org/0000-0001-7040-4228
Volkan ŞEN, DEUFM, Dept. of Urology, İzmir, Türkiye
https://orcid.org/0000-0003-2832-0682
Statistic Editor
Pembe KESKİNOĞLU, DEUFM, Dept. of Biostatistics
https://orcid.org/0000-0002-3459-1828
Language Editor
Leslie DEMİR
e-mail: leslie.demir@gmail.com
Advisory Board
Bayram YILMAZ, DEUFM, Dept. of Physiology, İzmir, Türkiye
https://orcid.org/0000-0002-2674-6535
Emel SOKULLU, Koç University, School of Medicine, Dept. of Biophysics, KUTTAM, İstanbul, Türkiye
https://orcid.org/0000-0003-1302-1997
Enver AKALIN, Albert Einstein College of Medicine, Dept. of Medicine (Nephrology), New York, USA
https://orcid.org/0000-0003-1341-5144
Gabor Michael HALMAGYI, University of Sydney, Dept. of Neurology, Sydney, Australia
https://orcid.org/0000-0002-9743-466X
İbrahim Emre BORA, DEUFM, Dept. of Mental Health and Diseases, İzmir, Türkiye
https://orcid.org/0000-0002-1598-6832
Şermin GENÇ, İzmir Biomedicine and Genome Center, DEU Institute of Health Sciences, Dept. of Molecular Biology and Genetics, İzmir, Türkiye
https://orcid.org/0000-0001-6126-7460
Please note that the order in which the Editors and Advisory Board appear on this page is alphabetical.
Types of Publications
Developments and Experiments in Health and Medicine requires that authors publish all experimental controls and make full datasets available where possible (see the guidelines on Supplementary Materials and references to unpublished data).
Manuscripts submitted to Developments and Experiments in Health and Medicine should neither be published previously nor be under consideration for publication in another journal.
Developments and Experiments in Health and Medicine accepts to use the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication” standards prepared by the International Committee of Medical Journal Editors-ICMJE (http://www.icmje.org/recommendations).
Authors are advised to follow the CONSORT guidelines for randomized trials, STROBE for observational studies, STARD for diagnostic/prognostic studies, PRISMA for systematic reviews and meta-analyses, ARRIVE for preclinical studies with experimental animals, TREND for non-randomized behavioral and community health interventional studies, and CARE guidelines for case reports. These reporting guidelines are available on the EQUATOR network (www.equator-network.org/home/) and on the National Library of Medicine-NLM “Research Reporting Guidelines and Initiatives” website (www.nlm.nih.gov/services/research_report_guide.html).
The main article types are listed below. Requirements for different types of articles are as follows:
- Research article: These are original research manuscripts. The work should provide a substantial amount of new information. Full experimental details must be provided so that the results can be reproduced. The structure should include a structured abstract, introduction, materials and methods, results, discussion, conclusion(s) (if appreciated), acknowledgement (if applicable), and references sections. The abstract should be structured as follows: objective(s), methods, results, conclusion(s). The length of the article should not exceed 3750 (250 abstract + 3500 body) words excluding the references, figures and tables. The article should include the most recent and relevant references in the field. Up to 45 references can be stated.
- Case reports: Should contain a non-structured abstract and three to five keywords both in Turkish and English, introduction, case presentation, discussion, conclusion(s) (if appreciated), acknowledgment (if applicable), and references sections. The length of the article should not exceed 1650 words (150 abstract + 1500 body) excluding the references, figures and tables. Case reports should optimally be accompanied by relevant figures to document findings. Up to 20 references can be provided. Informed consent should be obtained from the patients to report their cases. The Journal keeps the right to ask for original signed informed consents.
- Review articles: These manuscripts will only be considered when invited by the Editorial Board. Reviews should critically assess the current knowledge of the field. A non-structured abstract both in Turkish and English is needed. The length of the article should not exceed 5250 words (250 abstract + 5000 body) excluding the references, figures and tables. Up to 100 references can be provided.
- Letters to the Editor: Letters should be less than 750 words. No abstract is required for articles to be evaluated under this title. Three to five keywords both in Turkish and English should be provided. Up to 5 references should be stated. If the submitted letter is discussing an article published in the Developments and Experiments in Health and Medicine, it should be submitted at most within 4 months after the publication of the main article. Letters will also undergo peer review.
- Insights and Images: Submissions to the Insights and Images section should be of high-quality clinical pictures, radiology or surgical images that provide insight to the diagnosis or pathophysiology of a clinical problem or a solution. Text should be a succinct short clinical vignette or description and a brief discussion of the most relevant new information, such as a differential diagnosis, management, pathophysiology, or genetic basis. A non-structured abstract both in Turkish and English is needed. The length of the article should not exceed 1750 words (250 abstract + 1500 body) excluding the references, abstract, figures and tables. Up to 20 references can be provided. Informed consent should be obtained from the patients to report their cases. The Journal keeps the right to ask for original signed informed consents.
Submission Process
Manuscripts should be sent through the online submission system: (https://dergipark.org.tr/tr/pub/@tipdergisi)
The submitting author, who is generally the corresponding author, is responsible for the manuscript during the submission and peer review process. The submitting author must ensure that all eligible co-authors have been included in the author list (read the criteria to qualify for authorship) and that they have all read and approved the submitted version of the manuscript.
To submit your manuscript, register and login to the submission website. All co-authors can see the manuscript details in the submission system, if they register and log in using the e-mail address provided at the time of manuscript submission.
Developments and Experiments in Health and Medicine follows a double-blind reviewing procedure which means the author will remain anonymous to the reviewers throughout peer review. It is the responsibility of the author to anonymize the manuscript and any associated materials. Author names, affiliations and any other potentially identifying information should be removed from the manuscript text and any accompanying files (such as figures of supplementary material). Authors should avoid citing their own work in a way that could reveal their identity.
Although not mandatory, the Journal's editorial board welcomes reviewer suggestions who are expert in the relevant field with. Developments and Experiments in Health and Medicine also enables the authors to exclude reviewers. The names of proposed and excluded reviewers should be provided in the submission system, not in the cover letter.
All articles sent to the journal are evaluated by the Editorial Board in terms of their conformity with the scope of the journal and the writing rules. Editors may decide to reject the article or send it back to the author(s) for correction before sending it to the advisor's evaluation.
Revisions
Developments and Experiments in Health and Medicine is a double-blind journal and articles are sent to at least two expert advisors on the relevant subject. Developments and Experiments in Health and Medicine aims to inform the author(s) about the evaluation result within 6-8 weeks after the article is sent to the journal. The editor may request revision of the article, considering the advisors' suggestions. Revision should be completed within 30 days. If the revised version of the article is not sent to the journal on time, the article will be evaluated as a new application.
When your manuscript reaches the revision stage, you will be requested to format the manuscript according to the journal guidelines. When submitting a revised version of a paper, the author must submit a detailed “Response to reviewers” that states point by point how each issue raised by the reviewers has been covered and where it can be found (each reviewer's comment followed by the author’s reply) as well as a clear copy of the main document. The authors are required to copy the changes they make in the main text and other components of the article into the response letter.
Revised manuscripts must be submitted within 30 days from the date of the decision letter. If the submitting author(s) believe that additional time is required, they should request an extension before the initial 30-day period is over.
The final decision (acceptance/rejection) regarding the article is notified to the author by the editor. All authors accept the editor's corrections without changing the basic meaning.
April 29, 2026
Page
145-157